PTNQ vs ABEO โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ABEO Captures Institutional Edge (2โ2 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Abeona Therapeutics Inc. Common Stock (ABEO) driven by superior Valuation, Growth & Margin while PTNQ counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, PTNQ trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus ABEO at 18.7x Forward P/E and -186.1% operating margin (+2745.0% YoY). In options structure, PTNQ sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ABEO sits in BREAKDOWN (27th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | PTNQ | ABEO | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $149.2M | Larger Scale | ABEO |
| Trailing P/E Ratio Valuation | N/M | 18.7x | Lower Multiple | ABEO |
| Forward P/E Ratio Valuation | N/M | 18.7x | Lower Multiple | ABEO |
| Revenue Growth (YoY) Growth | N/A | +2745.0% | Higher Growth | ABEO |
| Operating Margin (TTM) Profitability | N/A | -186.1% | Higher Margin | ABEO |
| Net Profit Margin Profitability | N/A | -160.3% | Higher Margin | ABEO |
| Return on Equity (ROE) Capital Efficiency | N/A | -42.1% | Higher ROE | ABEO |
| 52-Week Range Position Momentum | 40% ($72โ$92) | 9% ($2โ$8) | Stronger Trend | PTNQ |
| Beta / 30D Volatility Risk Regime | 1.40ฮฒ ยท 35% Vol | 0.60ฮฒ ยท 149% Vol | Lower Realized Risk | PTNQ |
| Unified Institutional Score Composite Signal | 54.5 / 100 (HOLD) | 44.9 / 100 (HOLD) | Higher Composite | PTNQ |